Overview
Natalia Neparidze is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Neparidze is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Aspiration, and Splenectomy.
Her clinical research consists of co-authoring 39 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 York St, New Haven, CT 06510
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Trustees Of Columbia University In The City Of New York
Suzanne Lentzsch is an Oncologist and a Hematologist in New York, New York. Dr. Lentzsch is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy.
Yale University
Terri Parker is a Hematologist Oncology specialist and a Hematologist in New Haven, Connecticut. Dr. Parker is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Schnitzler Syndrome, Smoldering Multiple Myeloma, and Bone Marrow Aspiration.
Yale University
Su Lim is an Oncologist and a Hematologist Oncology provider in New Haven, Connecticut. Dr. Lim is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Hemochromatosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), Small Lymphocytic Lymphoma (SLL), and Chronic Lymphocytic Leukemia (CLL).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Multiple MyelomaDr. Neparidze isElite. Learn about Multiple Myeloma.
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. Neparidze isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- GTP Cyclohydrolase 1 DeficiencyDr. Neparidze isDistinguished. Learn about GTP Cyclohydrolase 1 Deficiency.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Relapsed Refractory Multiple Myeloma (RRMM)Dr. Neparidze isDistinguished. Learn about Relapsed Refractory Multiple Myeloma (RRMM).
- Schnitzler SyndromeDr. Neparidze isDistinguished. Learn about Schnitzler Syndrome.
- Smoldering Multiple MyelomaDr. Neparidze isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Deep Vein ThrombosisDr. Neparidze isAdvanced. Learn about Deep Vein Thrombosis.
- Drug-Induced ThrombocytopeniaDr. Neparidze isAdvanced. Learn about Drug-Induced Thrombocytopenia.
- Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
- Pseudocholinesterase DeficiencyDr. Neparidze isAdvanced. Learn about Pseudocholinesterase Deficiency.
- Pulmonary EmbolismDr. Neparidze isAdvanced. Learn about Pulmonary Embolism.
- Experienced
- Acute Eosinophilic PneumoniaDr. Neparidze isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Erythroid Leukemia (AEL)Dr. Neparidze isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Myeloblastic Leukemia with MaturationDr. Neparidze isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Adult Immune ThrombocytopeniaDr. Neparidze isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Neparidze isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Neparidze isExperienced. Learn about Anemia.